Changes in the incidence of transfusion reactions in hematological patients over the past 30 years
- 11 February 2022
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 62 (3) , 600-611
Abstract
Background: Patients with hematological diseases are polytransfused and often immunocompromised, therefore susceptible to transfusion reactions (TR). This study aims to document the incidence of TRs in adult hematological patients and assess the effect of changes in the production of blood components and transfusion practice on their occurrence.Study design and methods: Retrospective observational analysis of TRs reported from 1993 to 2019 was performed. For the analysis of the effect of changes on the incidence of TRs, the evaluated time was divided into two periods: the 1st period before the introduction of changes in production, when leukoreduced blood components were used only selectively, and the 2nd period, when semi‐automated method of production and universal leukoreduction was introduced.Results: The decrease in the incidence of TRs was observed for both red blood cell (RBC) and platelet concentrate (PC) transfusions in the 2nd period. Since platelet additive solution has been used, a further decrease in the incidence was reported. The decrease in incidence was also observed for delayed hemolytic/serological transfusion reactions and for transfusion‐transmitted bacterial infections. Four cases of incorrect blood transfusions were uniquely related to the hematological patients, caused by antigen loss and transfusion ordering after ABO‐incompatible hematopoietic stem cell transplantation.Discussion: Our results provided evidence that the introduction of tools offered by modern transfusion medicine: universal leukodepletion, plasma replacement with additive solutions, sensitive laboratory techniques, prophylactic antigen matching policy, informatization, and automatization, decreased the incidence of TRs and improved transfusion safety.Keywords
This publication has 46 references indexed in Scilit:
- Transfusion-related acute lung injury: incidence and risk factorsBlood, 2012
- Transfusion practice and safety: current status and possibilities for improvementVox Sanguinis, 2010
- An association between decreased cardiopulmonary complications (transfusion‐related acute lung injury and transfusion‐associated circulatory overload) and implementation of universal leukoreduction of blood transfusionsTransfusion, 2010
- Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactionsTransfusion, 2010
- DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic PatientsPLOS ONE, 2009
- Automating the transfusion service in the 21st centuryTransfusion, 2008
- Hemolytic Transfusion ReactionsTransfusion Medicine and Hemotherapy, 2008
- Clinical predictors of alloimmunization after red blood cell transfusionTransfusion, 2007
- Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injuryBlood, 2006
- Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactionsTransfusion, 1999